معرفی
Visalini Nair-Shalliker is a Senior Research Fellow at the Sydney School of Public Health within the Faculty of Medicine and Health at the University of Sydney. She is affiliated with the Prostate Cancer Stream and The Daffodil Centre, focusing on epidemiological research related to cancer risk factors, particularly prostate cancer. Her work integrates environmental, lifestyle, and molecular data to enhance understanding of disease progression and prevention.
Education: She holds a PhD in Epidemiology, with her doctoral research examining the relationship between sun exposure, vitamin D, and prostate cancer development.
Research Interests: Dr Nair-Shalliker’s research emphasizes prostate cancer risk factors, including vitamin D deficiency, UV exposure, and comorbidities such as diabetes and obesity. She leads clinical trials, notably the ProsD trial investigating high-dose vitamin D supplementation in prostate cancer patients. Additional areas include second primary cancers (e.g., melanoma and prostate cancer correlations) and the role of socioeconomic factors in cancer treatment accessibility.
Articles Trends: Her recent publications highlight advancements in prostate cancer epidemiology, melanoma’s role in cancer risk, and vitamin D’s impact on disease outcomes. She frequently collaborates on large-scale cohort studies (e.g., NSW 45 and Up Study) to analyze risk patterns and treatment disparities.
- Awards and Honors:
- COSA Best of Best Oral presentation 2022
- NSW Cancer Research Network Travel Grant 2018
- Australian Epidemiological Association Best Poster Award (2013)
- Novartis ANZUP Travel Award 2012
Advising and Grants: She mentors a current research student, Basil, investigating male breast cancer and prostate cancer associations. Her grants include overseeing the ProsD trial and analyzing prostate cancer biopsy practices in Australia. Collaborations extend to the Sydney Cancer Research Network and ANZUP.
Labs and Teams: Active member of The Daffodil Centre and the Sydney Cancer Research Network, contributing to multidisciplinary cancer research initiatives.
